This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Market Hustle: Stock Futures Lower as OECD Cuts Global Growth Outlook

NEW YORK (TheStreet) -- Stock futures were lower Tuesday as the Organization for Economic Cooperation and Development cut its global growth forecasts and a health care deal was announced that will make Bayer the largest over-the-counter drug seller in North America.


WATCH: More market update videos on TheStreet TV

Futures for the S&P 500 were off 5 over fair value to 1,873.75 while futures for the Dow Jones Industrial Average were slipping 35.55 over fair value to 16,426.0. Nasdaq futures were down 9.04 over fair value to 3,588.0.

  • In its Economic Outlook report, the OECD lowered its forecast for global economic growth from its November outlook, from 3.6% to 3.4% for 2014. It called on the European Central Bank to cut its interest rate, and take potentially additional measures to address low eurozone inflation. The organization said U.S. economic growth could expand at a 3.9% annual pace this quarter.
  • The U.S. trade deficit fell 3.6% to $40.4 billion in March, broadly in line with expectations.
  • Companies expected to see price action on Tuesday include Walt Disney (DIS - Get Report), Trip Advisor (TRIP), Athenahealth  (ATHN) and Groupon (GRPN).
  • Walt Disney is expected to post second-quarter earnings of 96 cents a share while Trip Advisor is slated to announce earnings of 55 cents a share. Groupon is forecast to post a loss of 3 cents a share for the first quarter. Athenahealth fell sharply in after-hours trading on Monday after Greenlight Capital's David Einhorn warned the company could drop up to 80% and said his fund had a short position in the stock.
  • Merck (MRK - Get Report)reported the sale of its consumer care business to Germany's Bayer for $14.2 billion on Monday. Bayer said the deal would make it the second-largest over-the-counter drug seller globally and the biggest one in North America.
  • Ukraine casualties continued to rise. France warned Russian President Vladimir Putin that he will face ongoing pressure for Ukraine to hold a May 25 presidential election.
  • Germany's DAX was 0.73% lower while the U.K. FTSE was off 0.50%. 
  • Markets closed higher Monday on better U.S. economic data after trading lower early in the session on poor Chinese manufacturing figures and Ukraine tensions.

-- By Jane Searle in New York

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
DIS $109.53 0.00%
MRK $57.60 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs